Maria Azmanova

MariaMaria obtained a BSc (First Class Honours) degree in Chemistry with Pharmaceutical and Forensic Science at the University of Bradford in 2017 and continued her studies for a Master of Chemistry degree, working in our group on the synthesis of novel metal-based complexes and the investigation of their anticancer activity. She graduated with a Master of Chemistry degree, with Distinction in 2018 and she was awarded the JOEL prize for best overall performance from her cohort of students. Her current PhD work is on the investigation of the biological properties of electron-deficient metal complexes.


3. Preclinical Anticancer Activity of an Electron‐Deficient Organoruthenium(II) Complex, J. J. Soldevila‐Barreda, M. Azmanova, A. Pitto‐Barry, P. A. Cooper, S. D. Shnyder, N. P. E. Barry, ChemMedChem, 2020, doi: 10.1002/cmdc.202000096. indicates equal contribution.

2. Anticancer activity of electron‐deficient metal complexes against colorectal cancer in vitro models
M. Azmanova, J. J. Soldevila-Barreda, H. Bani Hani, R. M. Lord, A. Pitto-Barry, S. Picksley, and N. P. E. Barry, ChemMedChem, 2019, 14, 1887-1893.

1. Schizophrenia: synthetic strategies and recent advances in drug design, M. Azmanova, A. Pitto-Barry, N. P. E. Barry, Medicinal Chemistry Communications, 2018, 9, 759-782